Feasibility of The Health Integrated Nutrition and Kidney Wellness Program
Part of paid clinical trials in Pittsburgh, Pennsylvania.
- Sponsor
- University of Pittsburgh
- Study ID
- NCT07518719
- Status
- Recruiting
Conditions
- Cardiovascular Disease
- Chronic Kidney Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- THINK-Well — BEHAVIORALSeven hybrid (online or in-person) group nutrition education sessions paired with food bucks and one individual consultation with a dietitian over 12-weeks.
- Enhanced Usual Care — OTHERTwo virtual group nutrition educational sessions provided by a trained educator.
Study Details
Purpose of the Study: This clinical trial will test whether a nutrition and kidney health program can work well for adults with kidney disease. The program was created with help from patients and community partners. Main Questions: How many eligible patients choose to join the program? How many participants finish the full 12-week program? How satisfied are participants with the program? What Participants Will Do: Participants will be assigned to a diet-focused lifestyle education series (THINK-Well Intervention) or enhance usual care. THINK-Well Intervention group will take part in 7 group education sessions over 12 weeks. Sessions will be online and in-person. Topics include eating to promote heart-kidney-and metabolic health, managing long-term health conditions, setting health goals, and sharing experiences with others who have chronic disease. Participants will practice meal preparation through cooking classes and have opportunity to apply lessons on choosing whole foods with food bucks provided. The enhanced usual care group will receive two virtual nutrition education sessions led by a trained educator over 12 weeks. Topics will be similar to standard education provided to people with kidney disease managed by a kidney doctor. Topics will be adapted from established resources from the National Kidney Foundation, American Kidney Fund, and American Heart Association.
Key Dates
- Start date
- Apr 24, 2026
- Status verified
- May 2026
- Primary completion
- Oct 31, 2026
- Completion
- Oct 31, 2026
Study Design
- Enrollment
- 45 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Experimental: THINK-WellHybrid (in-person and virtual) practical nutrition education with people living with kidney disease. Group sessions will enable social support from others with kidney disease, facilitate goal-setting and individualized problem-solving, discuss an integrated approach to nutrition for people with multiple health conditions, and develop basic culinary skills while encouraging a whole-food, heart-healthy diet. Participants will also receive financial assistance to purchase produce and opt-out 1:1 nutrition counseling.
- Active Comparator: Enhanced Usual CareThe enhanced usual care group will receive two virtual nutrition education sessions led by a trained educator over 12 weeks.
Primary Outcome Measure
Feasibility of Recruitment [ Time Frame: During the study recruitment period (anticipated up to 6 months) ]
Central Contacts
- Linda-Marie Lavenburg, DO, MS12679807722
- Manisha Jhamb, MD, MPH412-647-7062
Locations (5)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UPMC Kidney Clinic - Monroeville | Pittsburgh | Pennsylvania | 15146 | |
| UPMC Kidney Clinic - Oakland | Pittsburgh | Pennsylvania | 15213 | |
| UPMC Kidney Clinic - Shadyside | Pittsburgh | Pennsylvania | 15232 | |
| UPMC Kidney Clinic - Wexford | Pittsburgh | Pennsylvania | 15090 | |
| UPMC Matilda H. Theiss Health Center | Pittsburgh | Pennsylvania | 15219 |
Find similar trials in Pittsburgh, PA
Related Studies
- Chronic Kidney Disease in Children Prospective Cohort Study (CKiD)Recruiting · Johns Hopkins Bloomberg School of Public Health · Kansas City, Missouri
- Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal CenterRecruiting · University of Michigan · Ann Arbor, Michigan
- A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on HemodialysisPHASE3 · Recruiting · Amgen · Los Angeles, California
- A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and ProteinuriaPHASE3 · Recruiting · Bayer · Phoenix, Arizona